News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Patrick Hwu: Looking forward to meet Jason Luke at AACR25
Patrick Hwu and Jason Luke
Apr 9, 2025, 07:59

Patrick Hwu: Looking forward to meet Jason Luke at AACR25

Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post on X:

“Dr. Jason Luke is an associate professor of Medicine at UPMC Hillman Cancer Center, where he is associate director for Clinical Research and the director of the Immunotherapy and Drug Development Center.

He’s a very impactful clinical investigator working in immunotherapy and an amazing trumpet player.
Looking forward to playing together with The Check Points in a few weeks at AACR25!

Go give him a follow”

Patrick Hwu: Looking forward to meet Jason Luke at AACR25

More posts featuring Patrick Hwu.

AACR25 cancer Drug Development Center immunotherapy Jason Luke OncoDaily Oncology Patrick Hwu UPMC Hillman Cancer Center
Special Coverage
Voices
Sep 5, 2025, 10:49
Humaid Al-Shamsi: The Spirit of Dedicated Care that Makes BCI the Preferred Destination for Cancer Patients
Voices
Sep 5, 2025, 10:43
Launch of a New ESTRO Webinar Series
Science
Sep 5, 2025, 10:40
Talking With Adolescent and Young Adult Cancer Survivors About Health After Cancer - ACS Journals
Voices
Sep 5, 2025, 10:29
Lucia Borriello: Uncovering the Secrets of Tumor Dormancy and Metastasis
Voices
Sep 5, 2025, 10:18
Isabel Mestres: I Recently Contributed with an Op-Ed to Resolve Global Health’s New Report
Dialogues
Sep 5, 2025, 10:12
MASCC 2025 Presidential Training Fellowship Spotlight: Celia Díez de los Ríos de la Serna
Voices
Sep 5, 2025, 10:11
Staying Physically Active Isn't Just Personal Care: It's Professional Responsibility - American Cancer Society
Voices
Sep 5, 2025, 09:55
Florian Lordick: Chemoresistance of Novel Therapeutic Approaches for Esophageal Adenocarcinoma
Science
Sep 5, 2025, 09:41
Vivek Subbiah: How Aggressive Brain Tumors Exploit Glucose to Suppress Normal Activity
Voices
Sep 5, 2025, 08:57
Honoring a Life of Compassion and Impact - CancerWorld
Voices
Sep 5, 2025, 08:57
C/Can Advances Breast Imaging Training for Global Cities
FDA Approvals
Sep 5, 2025, 08:44
Olomorasib Receives FDA Breakthrough Therapy Designation for KRAS G12C-Mutant NSCLC